CARM |
Carisma Therapeutics Inc. |
Jun 26, 2024 |
1 |
$0 |
4 |
Jun 27, 2024 |
Director |
RPTX |
Repare Therapeutics Inc. |
Jun 17, 2024 |
1 |
$0 |
4 |
Jun 20, 2024 |
Director |
ARVN |
ARVINAS, INC. |
May 29, 2024 |
2 |
$0 |
4 |
May 31, 2024 |
Director |
HOWL |
Werewolf Therapeutics, Inc. |
May 24, 2024 |
1 |
$0 |
4 |
May 24, 2024 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Feb 7, 2024 |
1 |
$0 |
4 |
Feb 9, 2024 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Aug 9, 2023 |
3 |
-$502K |
4 |
Aug 10, 2023 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Jul 10, 2023 |
3 |
-$615K |
4 |
Jul 11, 2023 |
Director |
HOWL |
Werewolf Therapeutics, Inc. |
Jun 21, 2023 |
1 |
$0 |
4 |
Jun 23, 2023 |
Director |
ARVN |
ARVINAS, INC. |
Jun 15, 2023 |
2 |
$0 |
4 |
Jun 20, 2023 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Jun 9, 2023 |
6 |
-$715K |
4 |
Jun 9, 2023 |
Director |
RPTX |
Repare Therapeutics Inc. |
Jun 8, 2023 |
1 |
$0 |
4 |
Jun 12, 2023 |
Director |
CARM |
Carisma Therapeutics Inc. |
Jun 6, 2023 |
1 |
$0 |
4 |
Jun 8, 2023 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
May 9, 2023 |
3 |
-$794K |
4 |
May 10, 2023 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Apr 10, 2023 |
3 |
-$695K |
4 |
Apr 12, 2023 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Mar 13, 2023 |
3 |
-$853K |
4 |
Mar 14, 2023 |
President, Head of R&D, Director |
CARM |
Carisma Therapeutics Inc. |
Mar 7, 2023 |
3 |
$0 |
4 |
Mar 9, 2023 |
Director |
CARM |
Carisma Therapeutics Inc. |
Mar 7, 2023 |
0 |
$0 |
3 |
Mar 9, 2023 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Feb 6, 2023 |
3 |
-$1.08M |
4 |
Feb 8, 2023 |
President, Head of R&D, Director |
SNDX |
Syndax Pharmaceuticals Inc |
Feb 2, 2023 |
1 |
$914K |
4 |
Feb 3, 2023 |
President, Head of R&D, Director |
SNDX |
Syndax Pharmaceuticals Inc |
Sep 19, 2022 |
6 |
-$2.12M |
4 |
Sep 21, 2022 |
President, Head of R&D, Director |
SNDX |
Syndax Pharmaceuticals Inc |
Sep 14, 2022 |
12 |
-$4.4M |
4 |
Sep 16, 2022 |
President, Head of R&D, Director |
SNDX |
Syndax Pharmaceuticals Inc |
Jul 1, 2022 |
3 |
-$735K |
4 |
Jul 5, 2022 |
President, Head of R&D, Director |
ARVN |
ARVINAS, INC. |
Jun 16, 2022 |
1 |
$0 |
4 |
Jun 21, 2022 |
Director |
HOWL |
Werewolf Therapeutics, Inc. |
Jun 1, 2022 |
1 |
$0 |
4 |
Jun 3, 2022 |
Director |
RPTX |
Repare Therapeutics Inc. |
May 13, 2022 |
1 |
$0 |
4 |
May 16, 2022 |
Director |
ARVN |
ARVINAS, INC. |
Apr 14, 2022 |
5 |
-$1.13M |
4 |
Apr 18, 2022 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Apr 1, 2022 |
4 |
$530K |
4/A |
Apr 13, 2022 |
President, Head of R&D, Director |
SNDX |
Syndax Pharmaceuticals Inc |
Feb 2, 2022 |
1 |
$2.53M |
4 |
Feb 3, 2022 |
President, Head of R&D, Director |
ARVN |
ARVINAS, INC. |
Jan 14, 2022 |
6 |
-$1.12M |
4 |
Jan 19, 2022 |
Director |
SNDX |
Syndax Pharmaceuticals Inc |
Dec 17, 2021 |
3 |
-$320K |
4 |
Dec 20, 2021 |
Chief Executive Officer, Director |
SNDX |
Syndax Pharmaceuticals Inc |
Sep 17, 2021 |
6 |
-$905K |
4 |
Sep 21, 2021 |
Chief Executive Officer, Director |
ARVN |
ARVINAS, INC. |
Jun 8, 2021 |
1 |
$0 |
4 |
Jun 10, 2021 |
Director |
RPTX |
Repare Therapeutics Inc. |
May 13, 2021 |
1 |
$0 |
4 |
May 14, 2021 |
Director |